Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anabolic Potential of Adding 3-hydroxybutyrate (3-OHB) to Whey Protein in a Catabolic Inflammatory Disease Model: A Human Randomized Controlled Trial

NCT04064268 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04064268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04064268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anabolic Potential of Adding 3-hydroxybutyrate (3-OHB) to Whey Protein in a Catabolic Inflammatory Disease Model: A Human Randomized Controlled Trial
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Completed
Start date
June 17, 2019
Completion date
January 23, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catabolic state, endotoxemia, muscle loss, nutrition therapy, protein; disease